Program Description: 

This educational activity is designed to incorporate evidence-based pathophysiology, diagnosis, and/or treatment of urologic disorders into clinical practice. Speakers will utilize their personal, institutional and evidence-based experience to address patient health care conditions requiring clinical and surgical treatment.  Speakers will also utilize departmental quality improvement data, M&M data, and patient safety data to improve outcomes of urologic disease and other aspects of urologic  patients’ general health. Evidence-based data regarding the changing aspects/newer approaches to surgical disease will be analyzed, and critical issues related to urology within the broader scope of American health care will be discussed.  There are varying degrees to individuals’ knowledge regarding clinical and urologic treatments.  While individuals may be aware of varied treatment within the urologists’ armamentarium it is beneficial to address the topics from an evidence-based approach.

 

 
ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
 
AMA Credit Designation:
The Medical College of Wisconsin designates this Live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Hours of Participation for Allied Health Professionals:
The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals.
Target audience: 
  • Urology Faculty
  • Allied Healthcare Providers
  • Community Physicians
Learning objectives: 

At the end of this activity, I will be able to:

  1. To provide historical perspective and background for current controversy regarding testosterone replacement and cardiovascular risks
  2. To summarize the evidence supporting the increased cardiovascular risk of testosterone replacement
  3. To summarize the evidence refuting an increased cardiovascular risk of testosterone replacement
Faculty & credentials: 
Planning Committee:
Ken Jacobsohn, MD
William See, MD

 

Presenter:
Graham Luke Machen, MD

 

All persons in control of content have no relevant financial relationships to disclose with the exception of the following person: 
 

NameCompanyRole
   

 

In accordance with the ACCME®  Standards for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships.  These relationships were reviewed via the MCW conflict of interest resolution process and resolved.

 

Contact

Name: 
Tammy Janik
Phone number: 
+1 (414) 955-0880
Email: 
tjanik@mcw.edu
Session date: 
04/05/2019 - 7:30am to 8:30am CDT
Location: 
HUB- 6th Floor- RM 6520
8701 Watertown Plank Road
Milwaukee, WI 53226
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.00 Hours of Participation
    Hours of Participation credit.

Please login or register to take this course.